Literature DB >> 25922456

Sustained five-year benefit of autologous matrix-induced chondrogenesis for femoral acetabular impingement-induced chondral lesions compared with microfracture treatment.

A Fontana1, L de Girolamo2.   

Abstract

The repair of chondral lesions associated with femoroacetabular impingement requires specific treatment in addition to that of the impingement. In this single-centre retrospective analysis of a consecutive series of patients we compared treatment with microfracture (MFx) with a technique of enhanced microfracture autologous matrix-induced chondrogenesis (AMIC). Acetabular grade III and IV chondral lesions measuring between 2 cm(2) and 8 cm(2) in 147 patients were treated by MFx in 77 and AMIC in 70. The outcome was assessed using the modified Harris hip score at six months and one, two, three, four and five years post-operatively. The outcome in both groups was significantly improved at six months and one year post-operatively. During the subsequent four years the outcome in the MFx group slowly deteriorated, whereas that in the AMIC group remained stable. Six patients in the MFx group subsequently required total hip arthroplasty, compared with none in the AMIC group We conclude that the short-term clinical outcome improves in patients with acetabular chondral damage following both MFx and AMIC. However, the AMIC group had better and more durable improvement, particularly in patients with large (≥ 4 cm(2)) lesions. ©2015 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  AMIC technique; Acetabular chondral defects; Hip arthroscopy; Microfracture

Mesh:

Substances:

Year:  2015        PMID: 25922456     DOI: 10.1302/0301-620X.97B5.35076

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  32 in total

1.  [Hip arthroscopy].

Authors:  H Gollwitzer; I J Banke; J Schauwecker
Journal:  Orthopade       Date:  2016-02       Impact factor: 1.087

Review 2.  [Cartilage regeneration surgery on the hip : What is feasible?]

Authors:  Stefan Landgraeber; Marcus Jäger; Stefan Fickert
Journal:  Orthopade       Date:  2017-11       Impact factor: 1.087

3.  Autologous Membrane Induced Chondrogenesis (AMIC) for the treatment of acetabular chondral defect.

Authors:  Andrea Fontana
Journal:  Muscles Ligaments Tendons J       Date:  2016-12-21

4.  Outcomes of cartilage repair techniques for chondral injury in the hip-a systematic review.

Authors:  Naoki Nakano; Chetan Gohal; Andrew Duong; Olufemi R Ayeni; Vikas Khanduja
Journal:  Int Orthop       Date:  2018-03-13       Impact factor: 3.075

Review 5.  An evidence-based update on the management of articular cartilage defects in the hip.

Authors:  Karadi Hari Sunil Kumar; Malgorzata Garner; Vikas Khanduja
Journal:  J Clin Orthop Trauma       Date:  2022-03-17

6.  The Use of Autologous Matrix-Induced Chondrogenesis as a Surgical Treatment for Patients with the First Metatarsophalangeal Joint Osteoarthritis: Immediate and Medium-Term Results.

Authors:  Maxim Rinatovich Nurmukhametov; Maxim Anatolievich Makarov; Sergey Anatolievich Makarov; Evgeny Iosifovich Bialik; Valery Evgenievich Biaik; Vadim Andreevich Nesterenko
Journal:  Cartilage       Date:  2020-09-11       Impact factor: 3.117

Review 7.  The biology and clinical evidence of microfracture in hip preservation surgery.

Authors:  Chadwick John Green; Aswin Beck; David Wood; Ming H Zheng
Journal:  J Hip Preserv Surg       Date:  2016-02-26

8.  Arthroscopic autologous chondrocyte implantation in the hip for the treatment of full-thickness cartilage defects - A case series of 29 patients and review of the literature.

Authors:  Steffen Thier; Christel Weiss; Stefan Fickert
Journal:  SICOT J       Date:  2017-12-19

9.  Systematic review on the use of autologous matrix-induced chondrogenesis for the repair of articular cartilage defects in patients.

Authors:  Nafisa Shaikh; Matthew K T Seah; Wasim S Khan
Journal:  World J Orthop       Date:  2017-07-18

10.  What the Papers Say.

Authors:  Ajay Malviya
Journal:  J Hip Preserv Surg       Date:  2015-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.